In addition, we found no significant association between lnc-RAB11B-AS1 expression and age, race, history of hepatocarcinoma risk factors, T stage, M stage, treatment or treatment type, cancer first-degree relative, etc. Therefore, we speculate that high lnc-RAB11B-AS1 expression indicates a better clinical outcome in HCC patients. Here, RAB11B is linked to cancer.